Savoy Care Center in Mamou, LA

Savoy Care Center is a medicare and medicaid certified nursing home in Mamou, Louisiana. It is located in Evangeline county at 906 Cherry Street, Mamou, Louisiana 70554. You can reach out to the office of Savoy Care Center via phone at (337) 468-0347. This skilled nursing facility has 119 federally certified beds with average occupancy rate of 45.21%. Its legal business name is Mh3f Healthcare Management, Llc and has the following ownership type - For Profit - Corporation.

Savoy Care Center (Medicare CCN 195619) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 2005 (19 years certified) and the last quality survey was conducted in February, 2020.

Name	Savoy Care Center
Location	906 Cherry Street, Mamou, Louisiana
Certified By	Medicare and Medicaid
No. of Certified Beds	119
Occupancy Rate	45.21%
Medicare ID (CCN)	195619
Legal Business Name	Mh3f Healthcare Management, Llc
Ownership Type	For Profit - Corporation

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Savoy Care Center from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1194713206
Organization Name	MH3F HEALTHCARE MANAGEMENT, LLC
Doing Business As	SAVOY CARE CENTER
Address	906 Cherry St, Mamou, LA 70554
Phone Number	337-468-0347

News Archive

Global study provides insights into true psychosocial burden of rosacea

Galderma today released the findings of a global survey highlighting the need for dermatologists and doctors to proactively open a dialogue with patients about the true burden of rosacea and ways in which they can work together to achieve ‘clear' (IGA 0) skin.

Research explains how cells behave when placed in low oxygen environment

Research at the University of Liverpool has explained how cells behave when placed in a low oxygen environment, a development that could have implications for cancer patients and other serious illnesses.

Cancer mortality rates vary among major Hispanic ethnic groups

Cancer mortality rates vary considerably within the growing Hispanic population in the United States, with significant differences among the major Hispanic ethnic groups.

Alnara to announce Phase 3 study results of liprotamase for treating cystic fibrosis at the 23rd NACFC

Alnara Pharmaceuticals, Inc., a pharmaceutical company developing novel, non-systemic orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that results from a landmark, international Phase 3 study of the long-term safety and nutritional benefits of liprotamase for the treatment of pancreatic insufficiency in patients with cystic fibrosis (CF) will be presented at the 23rd Annual North American Cystic Fibrosis Conference (NACFC) being held October 15-17, 2009 in Minneapolis, Minnesota.

Read more Medical News

› Verified 4 days ago

NPI Number	1548993454
Organization Name	FLS LLC
Doing Business As	SAVOY CARE CENTER
Address	906 Cherry St, Mamou, LA 70554
Phone Number	337-468-0347

News Archive

Global study provides insights into true psychosocial burden of rosacea

Galderma today released the findings of a global survey highlighting the need for dermatologists and doctors to proactively open a dialogue with patients about the true burden of rosacea and ways in which they can work together to achieve ‘clear' (IGA 0) skin.

Research explains how cells behave when placed in low oxygen environment

Research at the University of Liverpool has explained how cells behave when placed in a low oxygen environment, a development that could have implications for cancer patients and other serious illnesses.

Cancer mortality rates vary among major Hispanic ethnic groups

Cancer mortality rates vary considerably within the growing Hispanic population in the United States, with significant differences among the major Hispanic ethnic groups.

Alnara to announce Phase 3 study results of liprotamase for treating cystic fibrosis at the 23rd NACFC

Alnara Pharmaceuticals, Inc., a pharmaceutical company developing novel, non-systemic orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that results from a landmark, international Phase 3 study of the long-term safety and nutritional benefits of liprotamase for the treatment of pancreatic insufficiency in patients with cystic fibrosis (CF) will be presented at the 23rd Annual North American Cystic Fibrosis Conference (NACFC) being held October 15-17, 2009 in Minneapolis, Minnesota.

Read more Medical News

› Verified 4 days ago

Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Savoy Care Center are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Savoy Care Center give to their patients.

Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

Global study provides insights into true psychosocial burden of rosacea

Galderma today released the findings of a global survey highlighting the need for dermatologists and doctors to proactively open a dialogue with patients about the true burden of rosacea and ways in which they can work together to achieve ‘clear' (IGA 0) skin.

Research explains how cells behave when placed in low oxygen environment

Research at the University of Liverpool has explained how cells behave when placed in a low oxygen environment, a development that could have implications for cancer patients and other serious illnesses.

Cancer mortality rates vary among major Hispanic ethnic groups

Cancer mortality rates vary considerably within the growing Hispanic population in the United States, with significant differences among the major Hispanic ethnic groups.

Alnara to announce Phase 3 study results of liprotamase for treating cystic fibrosis at the 23rd NACFC

Alnara Pharmaceuticals, Inc., a pharmaceutical company developing novel, non-systemic orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that results from a landmark, international Phase 3 study of the long-term safety and nutritional benefits of liprotamase for the treatment of pancreatic insufficiency in patients with cystic fibrosis (CF) will be presented at the 23rd Annual North American Cystic Fibrosis Conference (NACFC) being held October 15-17, 2009 in Minneapolis, Minnesota.

Read more Medical News

› Verified 4 days ago

Number of Facility Reported Incidents	0
Number of Substantiated Complaints	0
Number of Fines	0
Total Amount of Fines in Dollars	$0
Number of Payment Denials	0
Total Number of Penalties	0

The resident survey data of Savoy Care Center is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience Measure	Provider	National Avg.
Percentage of long-stay residents whose need for help with daily activities has increased	12.43	14.46
Percentage of long-stay residents who lose too much weight	5.23	5.51
Percentage of low risk long-stay residents who lose control of their bowels or bladder	13.19	48.41
Percentage of long-stay residents with a catheter inserted and left in their bladder	6.5	1.79
Percentage of long-stay residents with a urinary tract infection	10.87	2.65
Percentage of long-stay residents who have depressive symptoms	25.49	5.05
Percentage of long-stay residents who were physically restrained	0	0.23
Percentage of long-stay residents experiencing one or more falls with major injury	0.9	3.36
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine	89.24	93.87
Percentage of long-stay residents who received an antipsychotic medication	26.9	14.2
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine	54.72	83.88
Percentage of short-stay residents who newly received an antipsychotic medication	0	1.79
Percentage of long-stay residents whose ability to move independently worsened	12.14	17.09
Percentage of long-stay residents who received an antianxiety or hypnotic medication	48.82	19.7
Percentage of high risk long-stay residents with pressure ulcers	18.75	7.32
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine	98.03	95.98